CDKN1B Back

cyclin-dependent kinase inhibitor 1B (p27, Kip1)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of CDKN1B

This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state.

Community Annotation of CDKN1B Add / Edit CDKN1B: Annotations

No community annotations yet for CDKN1B.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

CDKN1B is highly significantly mutated in
combined cohort
PanCan
37 patients (0%)
CDKN1B is significantly mutated in
Carcinoid
CARC
5 patients (9%)
Breast
BRCA
7 patients (0%)
CDKN1B is near significance in
Endometrial
UCEC
7 patients (2%)
Lung adenocarcinoma
LUAD
4 patients (0%)

Click on a tumor type to see its full list of significant genes.

Data details


Mutation list for CDKN1B